These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22413811)

  • 1. Paradoxical bulging of muscle after injection of botulinum neurotoxin type A into hypertrophied masseter muscle.
    Lee SJ; Kang JM; Kim YK; Park J; Kim DY
    J Dermatol; 2012 Sep; 39(9):804-5. PubMed ID: 22413811
    [No Abstract]   [Full Text] [Related]  

  • 2. Paradoxical masseteric bulging after botulinum neurotoxin type A injection.
    Sandhu S; Shaefer J
    BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38749514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Botulinum Toxin Injection into Masseter Muscles Affect Subcutaneous Thickness?
    Park G; Choi YC; Bae JH; Kim ST
    Aesthet Surg J; 2018 Feb; 38(2):192-198. PubMed ID: 29117291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications of botulinum toxin injection for masseter hypertrophy: Incidence rate from 2036 treatments and summary of causes and preventions.
    Peng HP; Peng JH
    J Cosmet Dermatol; 2018 Feb; 17(1):33-38. PubMed ID: 29250900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Botulinum Toxin in Treating Asian Indian Patients with Masseter Hypertrophy: A 4-Year Follow-Up Study.
    Shome D; Khare S; Kapoor R
    Plast Reconstr Surg; 2019 Sep; 144(3):390e-396e. PubMed ID: 31461011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasonographic Considerations for Safe and Efficient Botulinum Neurotoxin Injection in Masseteric Hypertrophy.
    Lee HJ; Jung SJ; Kim ST; Kim HJ
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33406757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Literature review of the adverse events associated with botulinum toxin injection for the masseter muscle hypertrophy.
    Yeh YT; Peng JH; Peng HP
    J Cosmet Dermatol; 2018 Oct; 17(5):675-687. PubMed ID: 30091170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of masseter hypertrophy for tailored botulinum toxin type A treatment.
    Xie Y; Zhou J; Li H; Cheng C; Herrler T; Li Q
    Plast Reconstr Surg; 2014 Aug; 134(2):209e-218e. PubMed ID: 25068343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Cadaveric Study of Dye Spreading: Determining the Ideal Injection Pattern for Masseter Hypertrophy.
    Sermswan P; Tansatit T; Meevassana J; Panchaprateep R
    Dermatol Surg; 2021 Oct; 47(10):1354-1358. PubMed ID: 34417381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional CT might be a potential evaluation modality in correction of asymmetrical masseter muscle hypertrophy by botulinum toxin injection.
    No YA; Ahn BH; Kim BJ; Kim MN; Hong CK
    J Cosmet Laser Ther; 2016; 18(2):113-5. PubMed ID: 26073120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anatomical Considerations When Treating Compensatory Hypertrophy of the Upper Part of the Masseter after Long-Term Botulinum Neurotoxin Type A Injections.
    Lee KL; Cho HJ; Bae H; Park HJ; Park MS; Kim HJ
    Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32235784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multicenter Phase II Study Evaluating the Safety and Efficacy of Botulax in Asian Patients with Benign Masseteric Hypertrophy.
    Lee JS; Son HS; Kim BJ; Lee YW
    Plast Reconstr Surg; 2024 May; 153(5):910e-918e. PubMed ID: 37335589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of masseteric hypertrophy with botulinum toxin: a report of two cases.
    Baş B; Ozan B; Muğlali M; Celebi N
    Med Oral Patol Oral Cir Bucal; 2010 Jul; 15(4):e649-52. PubMed ID: 20173718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of botulinum toxin type A on contouring of the lower face.
    Choe SW; Cho WI; Lee CK; Seo SJ
    Dermatol Surg; 2005 May; 31(5):502-7; discussion 507-8. PubMed ID: 15962731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound-Guided Botulinum Neurotoxin Injection for Masseter Hypertrophy Based on the Structural Pattern of Deep Inferior Tendon and Masseteric Contraction.
    Wang YH; Chang SL; Hu S; Huang YL
    Plast Reconstr Surg; 2022 Jul; 150(1):240e-242e. PubMed ID: 35767638
    [No Abstract]   [Full Text] [Related]  

  • 16. The Masseter Muscle and Its Role in Facial Contouring, Aging, and Quality of Life: A Literature Review.
    Almukhtar RM; Fabi SG
    Plast Reconstr Surg; 2019 Jan; 143(1):39e-48e. PubMed ID: 30303926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type A for the treatment of hypertrophy of the masseter muscle.
    Kim NH; Park RH; Park JB
    Plast Reconstr Surg; 2010 Jun; 125(6):1693-1705. PubMed ID: 20517093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between Conventional Blind Injections and Ultrasound-Guided Injections of Botulinum Toxin Type A into the Masseter: A Clinical Trial.
    Bae H; Kim J; Seo KK; Hu KS; Kim ST; Kim HJ
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32932891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of botulinum toxin type A in masseter muscle hypertrophy: long-term effects and lasting improvement].
    Aydil B; Başaran B; Unsaler S; Süoğlu Y
    Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):249-53. PubMed ID: 22991984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin for masseter hypertrophy.
    Fedorowicz Z; van Zuuren EJ; Schoones J
    Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD007510. PubMed ID: 24018587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.